FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304807089> ?p ?o ?g. }

• W4304807089 endingPage "3413" @default.
• W4304807089 startingPage "3405" @default.
• W4304807089 abstract "To evaluate OC-01 [varenicline solution nasal spray (VNS)] tear production and symptom outcomes in patients with dry eye disease by age, gender, race, ethnicity, and artificial tear use status.Adults ≥22 years of age diagnosed with dry eye disease, with Ocular Surface Disease Index score ≥23, corneal fluorescein staining score ≥2 in ≥1 region or ≥4 for all regions, and baseline Schirmer Test Score (STS) ≤10 mm, with no restrictions on eye dryness score (EDS). Efficacy was assessed using integrated data from ONSET-1 and ONSET-2 [vehicle control (VC), n=294; OC-01 VNS 0.03 mg, n=308]. Subgroups included age (≤55, 56-65, >65 years), gender (male, female), race (White, Black or African American), ethnicity (Hispanic or Latino, Not Hispanic or Latino), and artificial tear use (yes, no). Analysis of covariance models, with the covariates treatment, study site, and baseline severity measures, were used to calculate treatment-VC differences. Consistency of effect among subgroups was evaluated by conducting interaction tests.Consistency of treatment effect across subgroups was observed for all endpoints, with P value for all treatment-subgroup interaction terms >0.05. For % of patients with ≥10mm improvement in STS and least squares (LS) mean change from baseline in STS and EDS, there was improvement in tear production across demographic group categories. Artificial tear use did not change STS or EDS outcomes with OC-01 VNS.OC-01 VNS improved tear production and patient-reported symptom outcomes across a broad range of patients by age, gender, race, and ethnicity, and regardless of artificial tear use status at baseline. OC-01 VNS demonstrated a consistent benefit across an extensive range of patients with dry eye disease." @default.
• W4304807089 created "2022-10-13" @default.
• W4304807089 creator A5019962224 @default.
• W4304807089 creator A5032418778 @default.
• W4304807089 creator A5041732496 @default.
• W4304807089 creator A5050827732 @default.
• W4304807089 creator A5050905083 @default.
• W4304807089 creator A5057926346 @default.
• W4304807089 creator A5069525344 @default.
• W4304807089 creator A5071854637 @default.
• W4304807089 creator A5090838299 @default.
• W4304807089 date "2022-10-01" @default.
• W4304807089 modified "2023-09-26" @default.
• W4304807089 title "OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use" @default.
• W4304807089 cites W1902102829 @default.
• W4304807089 cites W2004698731 @default.
• W4304807089 cites W2027975733 @default.
• W4304807089 cites W2098931866 @default.
• W4304807089 cites W2136938154 @default.
• W4304807089 cites W2144919760 @default.
• W4304807089 cites W2340320857 @default.
• W4304807089 cites W2346421161 @default.
• W4304807089 cites W2596272934 @default.
• W4304807089 cites W2605592441 @default.
• W4304807089 cites W2724132216 @default.
• W4304807089 cites W2735923669 @default.
• W4304807089 cites W2737642784 @default.
• W4304807089 cites W2737787547 @default.
• W4304807089 cites W2739359388 @default.
• W4304807089 cites W2911961397 @default.
• W4304807089 cites W2952425877 @default.
• W4304807089 cites W2999879907 @default.
• W4304807089 cites W3036870694 @default.
• W4304807089 cites W3106908696 @default.
• W4304807089 cites W3142116570 @default.
• W4304807089 cites W3212838083 @default.
• W4304807089 cites W4200467235 @default.
• W4304807089 doi "https://doi.org/10.2147/opth.s383091" @default.
• W4304807089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36249445" @default.
• W4304807089 hasPublicationYear "2022" @default.
• W4304807089 type Work @default.
• W4304807089 citedByCount "0" @default.
• W4304807089 crossrefType "journal-article" @default.
• W4304807089 hasAuthorship W4304807089A5019962224 @default.
• W4304807089 hasAuthorship W4304807089A5032418778 @default.
• W4304807089 hasAuthorship W4304807089A5041732496 @default.
• W4304807089 hasAuthorship W4304807089A5050827732 @default.
• W4304807089 hasAuthorship W4304807089A5050905083 @default.
• W4304807089 hasAuthorship W4304807089A5057926346 @default.
• W4304807089 hasAuthorship W4304807089A5069525344 @default.
• W4304807089 hasAuthorship W4304807089A5071854637 @default.
• W4304807089 hasAuthorship W4304807089A5090838299 @default.
• W4304807089 hasBestOaLocation W43048070891 @default.
• W4304807089 hasConcept C118487528 @default.
• W4304807089 hasConcept C126322002 @default.
• W4304807089 hasConcept C137403100 @default.
• W4304807089 hasConcept C144024400 @default.
• W4304807089 hasConcept C19165224 @default.
• W4304807089 hasConcept C2778837293 @default.
• W4304807089 hasConcept C71924100 @default.
• W4304807089 hasConceptScore W4304807089C118487528 @default.
• W4304807089 hasConceptScore W4304807089C126322002 @default.
• W4304807089 hasConceptScore W4304807089C137403100 @default.
• W4304807089 hasConceptScore W4304807089C144024400 @default.
• W4304807089 hasConceptScore W4304807089C19165224 @default.
• W4304807089 hasConceptScore W4304807089C2778837293 @default.
• W4304807089 hasConceptScore W4304807089C71924100 @default.
• W4304807089 hasLocation W43048070891 @default.
• W4304807089 hasLocation W43048070892 @default.
• W4304807089 hasLocation W43048070893 @default.
• W4304807089 hasOpenAccess W4304807089 @default.
• W4304807089 hasPrimaryLocation W43048070891 @default.
• W4304807089 hasRelatedWork W1991849106 @default.
• W4304807089 hasRelatedWork W1998054151 @default.
• W4304807089 hasRelatedWork W2060033748 @default.
• W4304807089 hasRelatedWork W2354640403 @default.
• W4304807089 hasRelatedWork W2587436937 @default.
• W4304807089 hasRelatedWork W3029036527 @default.
• W4304807089 hasRelatedWork W3030537508 @default.
• W4304807089 hasRelatedWork W3041253394 @default.
• W4304807089 hasRelatedWork W4289534908 @default.
• W4304807089 hasRelatedWork W4300868522 @default.
• W4304807089 hasVolume "Volume 16" @default.
• W4304807089 isParatext "false" @default.
• W4304807089 isRetracted "false" @default.
• W4304807089 workType "article" @default.